AARP is putting increased pressure on the pharmaceutical industry after launching its Stop Rx Greed campaign last month, according to an MM&M report.
The organization found in a survey before the campaign’s launch that 72 percent of individuals age 50 and above expressed concern about the cost of their medicines.
“Success for us means, for instance, two of the major federal initiatives we’re behind, that deal with bringing more competition and allowing generics to come to market sooner, have passed a major committee in the House,” AARP Senior Vice President of Campaigns John Hishta said. “We’re making progress in individual states, too, where we’re starting to see a lot of legislation moving.”
To read the full report on MM&M, click here.